Literature DB >> 10877287

Time-dependent ROC curves for censored survival data and a diagnostic marker.

P J Heagerty1, T Lumley, M S Pepe.   

Abstract

ROC curves are a popular method for displaying sensitivity and specificity of a continuous diagnostic marker, X, for a binary disease variable, D. However, many disease outcomes are time dependent, D(t), and ROC curves that vary as a function of time may be more appropriate. A common example of a time-dependent variable is vital status, where D(t) = 1 if a patient has died prior to time t and zero otherwise. We propose summarizing the discrimination potential of a marker X, measured at baseline (t = 0), by calculating ROC curves for cumulative disease or death incidence by time t, which we denote as ROC(t). A typical complexity with survival data is that observations may be censored. Two ROC curve estimators are proposed that can accommodate censored data. A simple estimator is based on using the Kaplan-Meier estimator for each possible subset X > c. However, this estimator does not guarantee the necessary condition that sensitivity and specificity are monotone in X. An alternative estimator that does guarantee monotonicity is based on a nearest neighbor estimator for the bivariate distribution function of (X, T), where T represents survival time (Akritas, M. J., 1994, Annals of Statistics 22, 1299-1327). We present an example where ROC(t) is used to compare a standard and a modified flow cytometry measurement for predicting survival after detection of breast cancer and an example where the ROC(t) curve displays the impact of modifying eligibility criteria for sample size and power in HIV prevention trials.

Entities:  

Mesh:

Year:  2000        PMID: 10877287     DOI: 10.1111/j.0006-341x.2000.00337.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  913 in total

1.  MGMT Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials.

Authors:  Monika E Hegi; Els Genbrugge; Thierry Gorlia; Roger Stupp; Mark R Gilbert; Olivier L Chinot; L Burt Nabors; Greg Jones; Wim Van Criekinge; Josef Straub; Michael Weller
Journal:  Clin Cancer Res       Date:  2018-12-04       Impact factor: 12.531

2.  A C-index for recurrent event data: Application to hospitalizations among dialysis patients.

Authors:  Sehee Kim; Douglas E Schaubel; Keith P McCullough
Journal:  Biometrics       Date:  2017-08-03       Impact factor: 2.571

3.  Comparing two correlated C indices with right-censored survival outcome: a one-shot nonparametric approach.

Authors:  Le Kang; Weijie Chen; Nicholas A Petrick; Brandon D Gallas
Journal:  Stat Med       Date:  2014-11-17       Impact factor: 2.373

4.  Prediction based classification for longitudinal biomarkers.

Authors:  A S Foulkes; L Azzoni; X Li; M A Johnson; C Smith; K Mounzer; L J Montaner
Journal:  Ann Appl Stat       Date:  2010-09       Impact factor: 2.083

5.  Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions.

Authors:  C-R Pradeep; A Zeisel; W J Köstler; M Lauriola; J Jacob-Hirsch; B Haibe-Kains; N Amariglio; N Ben-Chetrit; A Emde; I Solomonov; G Neufeld; M Piccart; I Sagi; C Sotiriou; G Rechavi; E Domany; C Desmedt; Y Yarden
Journal:  Oncogene       Date:  2011-12-05       Impact factor: 9.867

6.  Adjusting confounders in ranking biomarkers: a model-based ROC approach.

Authors:  Tao Yu; Jialiang Li; Shuangge Ma
Journal:  Brief Bioinform       Date:  2012-03-06       Impact factor: 11.622

7.  Non-parametric estimation of a time-dependent predictive accuracy curve.

Authors:  P Saha-Chaudhuri; P J Heagerty
Journal:  Biostatistics       Date:  2012-06-25       Impact factor: 5.899

8.  Challenges in Predicting Recurrence After Resection of Node-Negative Non-Small Cell Lung Cancer.

Authors:  Lucas W Thornblade; Michael S Mulligan; Katherine Odem-Davis; Billanna Hwang; Rachel L Waworuntu; Erika M Wolff; Larry Kessler; Douglas E Wood; Farhood Farjah
Journal:  Ann Thorac Surg       Date:  2018-07-19       Impact factor: 4.330

9.  Predictive accuracy of markers or risk scores for interval censored survival data.

Authors:  Yuan Wu; Xiaofei Wang; Jiaxing Lin; Beilin Jia; Kouros Owzar
Journal:  Stat Med       Date:  2020-04-15       Impact factor: 2.373

10.  Comparative pharmacogenetic analysis of risk polymorphisms in Caucasian and Vietnamese children with acute lymphoblastic leukemia: prediction of therapeutic outcome?

Authors:  Phuong Thu Vu Hoang; Jérôme Ambroise; Anne-France Dekairelle; Jean-François Durant; Valentina Butoescu; Vu Luan Dang Chi; Nghia Huynh; Tan Binh Nguyen; Annie Robert; Christiane Vermylen; Jean-Luc Gala
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.